Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk Factors.
Adrian H HealdDavid A JenkinsRichard WilliamsMatthew SperrinRajshekhar N MudaliarAkheel SyedAsma NaseemKelly A Bowden DaviesYonghong PengNiels PeekWilliam OllierSimon G AndersonGayathri DelanerolleJ Martin GibsonPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
Following confirmed infection with COVID-19 a number of factors are associated with mortality in individuals with T2DM. Prescription of metformin, SGLT2is or GLP-1 agonists and non-smoking status appeared to be associated with a reduced the risk of death for people with T2DM. Age, male sex and social disadvantage are associated with an increased risk of death.